Polymixin-b: Skin hyperpigmentation: case report.

B Author Information b An event is serious (based on the ICH definition) when the patient outcome is: * death * life-threatening * hospitalisation * disability * congenital anomaly * other medically important event A 68-year-old man developed skin hyperpigmentation during treatment with polymixin-B for multidrug-resistant I Klebsiella pneumoniae i infection (KPI). After 60 days of stopping polymixin-B, the hyperpigmentation returned to normal and desquamation also improved. Polymyxin B-Induced Skin Hyperpigmentation. [Extracted from the article]